antibody drug | The Epoch Times

FDA Pulls Authorization for Evusheld, Says It’s Ineffective Against New COVID Mutations

Evusheld has become the latest COVID-19 antibody drug to lose federal authorization after it was deemed ineffective against the dominant versions of the virus. The U.S. Food and Drug Administration ...

January 27, 2023BY Bill Pan

AstraZeneca’s COVID-19 Prevention Drug Granted Emergency Authorization for Immune Compromised

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization on Dec. 8 for an AstraZeneca COVID-19 antibody ...

December 9, 2021BY Katabella Roberts

FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization

Eli Lilly’s COVID-19 antibody-drug has been granted emergency use authorization by the Food and Drug Administration (FDA), widening ...

February 10, 2021BY Isabel van Brugen

US to Pay Eli Lilly $375 Million for 300,000 Vials of Experimental COVID-19 Antibody Drug

The U.S. government will pay Eli Lilly $375 million to secure an initial supply of 300,000 vials of ...

October 28, 2020BY Bill Pan